Precision Health Clinical Trials
Detection of Tumor DNA Through Cervical Smear and Liquid Biopsy in Endometrial Cancer Patients and Evaluation of Prognostic and Predictive Values of Tumor DNA Assay
Condition: Endometrial Cancer
Intervention:
Sponsor: Yonsei University
Recruiting
Intervention:
Sponsor: Yonsei University
Recruiting
For more information, visit the Study URL.
Familial and Functional Study of Genetic Variants Identified in People With Schizophrenia, Bipolar Disorder, Autism Spectrum Disorder or Resistant Depression
Condition: Psychiatric Disorder
Intervention: Genetic: study of the transmission of genetic variants
Sponsor: Fondation FondaMental
Not yet recruiting
Intervention: Genetic: study of the transmission of genetic variants
Sponsor: Fondation FondaMental
Not yet recruiting
For more information, visit the Study URL.
'Lung Health Check' Biomarker Study
Conditions: Lung Cancer; Cancer
Intervention: Diagnostic Test: Blood Specimen
Sponsors: Royal Marsden NHS Foundation Trust; Royal Brompton & Harefield NHS Foundation Trust; Imperial College London; Royal Marsden Partners Cancer Alliance
Recruiting
Intervention: Diagnostic Test: Blood Specimen
Sponsors: Royal Marsden NHS Foundation Trust; Royal Brompton & Harefield NHS Foundation Trust; Imperial College London; Royal Marsden Partners Cancer Alliance
Recruiting
For more information, visit the Study URL.
Functional Precision Oncology to Predict, Prevent, and Treat Early Metastatic Recurrence of TNBC
Condition: Breast Cancer Recurrent
Intervention: Other: Functional Precision Oncology
Sponsors: University of Utah; United States Department of Defense
Recruiting
Intervention: Other: Functional Precision Oncology
Sponsors: University of Utah; United States Department of Defense
Recruiting
For more information, visit the Study URL.
THIO Sequenced With Cemiplimab in Advanced NSCLC
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: 6-Thio-2'-Deoxyguanosine; Drug: Cemiplimab
Sponsor: Maia Biotechnology
Recruiting
Interventions: Drug: 6-Thio-2'-Deoxyguanosine; Drug: Cemiplimab
Sponsor: Maia Biotechnology
Recruiting
For more information, visit the Study URL.
Antibiotyping and Prevalence of Virulent Genotypes Among Helicobacter Pylori and Their Impact on Response to Therapy
Condition: H Pylori Infection
Interventions: Genetic: detection of vacuolating cytotoxin A (Vac A) and cytotoxin-associated gene A (Cag A) virulent H.Pylori genotypes by polymerase chain reaction amplification(PCR) in gastric biopsies :; Diagnostic Test: Culture and sensitivity of endoscopic gastric biopsies:; Other: Histopathological examination endoscopic gastric biopsies:; Procedure: Upper endoscopy; Drug: empirical H.pylori regimens; Diagnostic Test: H.Pylori Ag in stool
Sponsor: Assiut University
Not yet recruiting
Interventions: Genetic: detection of vacuolating cytotoxin A (Vac A) and cytotoxin-associated gene A (Cag A) virulent H.Pylori genotypes by polymerase chain reaction amplification(PCR) in gastric biopsies :; Diagnostic Test: Culture and sensitivity of endoscopic gastric biopsies:; Other: Histopathological examination endoscopic gastric biopsies:; Procedure: Upper endoscopy; Drug: empirical H.pylori regimens; Diagnostic Test: H.Pylori Ag in stool
Sponsor: Assiut University
Not yet recruiting
For more information, visit the Study URL.
BioMEL- Diagnostic and Prognostic Factors in Melanoma.
Conditions: Melanoma; Melanoma in Situ; Dysplastic Nevi; Mole (Dermatology); Image; Mutation
Intervention: Diagnostic Test: Imaging
Sponsor: Region Skane
Recruiting
Intervention: Diagnostic Test: Imaging
Sponsor: Region Skane
Recruiting
For more information, visit the Study URL.
Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in MDS
Conditions: Whole Genome Sequencing; Myelodysplastic Syndromes
Intervention: Device: ChromoSeq
Sponsors: Washington University School of Medicine; American Society of Hematology
Recruiting
Intervention: Device: ChromoSeq
Sponsors: Washington University School of Medicine; American Society of Hematology
Recruiting
For more information, visit the Study URL.
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
Conditions: Cancer; Liver Cirrhosis; Chronic Hepatitis; Hepatitis B; Hepatitis C; Diabetes; COPD
Intervention: Diagnostic Test: Multi-analyte Blood Test
Sponsor: Helio Genomics
Recruiting
Intervention: Diagnostic Test: Multi-analyte Blood Test
Sponsor: Helio Genomics
Recruiting
For more information, visit the Study URL.
Multi-analyte Blood Test Clinical Trial
Conditions: Liver Cirrhosis; Liver Cancer; HCC; Hepatocellular Carcinoma
Intervention: Diagnostic Test: Multi-analyte Blood Test
Sponsor: Helio Genomics
Recruiting
Intervention: Diagnostic Test: Multi-analyte Blood Test
Sponsor: Helio Genomics
Recruiting
For more information, visit the Study URL.